Bausch Health Companies Inc. (BHC) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
BHC Revenue Growth
Revenue Breakdown (FY 2025)
BHC's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
BHC Revenue Analysis (2014–2025)
As of May 8, 2026, Bausch Health Companies Inc. (BHC) generated trailing twelve-month (TTM) revenue of $10.55 billion, reflecting strong growth of +10.5% year-over-year. The most recent quarter (Q1 2026) recorded $2.49 billion in revenue, down 12.3% sequentially.
Looking at the longer-term picture, BHC's 5-year compound annual growth rate (CAGR) stands at +5.4%, indicating steady revenue expansion. The company achieved its highest annual revenue of $10.45 billion in 2025, representing a new all-time high.
Revenue diversification analysis shows BHC's business is primarily driven by Product (49%), Pharmaceutical Products (23%), and Device Products (12%).
When compared to Healthcare sector peers including PBH (-1.3% YoY), PRGO (-3.6% YoY), and BLCO (+7.8% YoY), BHC has outperformed the peer group in terms of revenue growth. Compare BHC vs PBH →
BHC Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| BHCCurrent | $10.6B | +10.5% | +5.4% | 21.3% | |
 PBH | $1.1B | -1.3% | +3.4% | 29.6% | |
 PRGO | $4.3B | -3.6% | +0.8% | 8.1% | |
 BLCO | $5.1B | +7.8% | +8.4% | 3.7% | |
 COO | $4.1B | +5.7% | +11.0% | 16.7% | |
 ABT | $42.0B | +6.4% | +5.6% | 16.3% |
BHC Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $10.45B | +8.5% | $6.36B | 60.9% | $2.22B | 21.3% |
| 2024 | $9.63B | +9.9% | $6.84B | 71.1% | $1.55B | 16.1% |
| 2023 | $8.76B | +7.8% | $6.20B | 70.8% | $963.0M | 11.0% |
| 2022 | $8.12B | -3.7% | $5.76B | 70.9% | $454.0M | 5.6% |
| 2021 | $8.43B | +5.1% | $6.04B | 71.6% | $450.0M | 5.3% |
| 2020 | $8.03B | -6.7% | $5.78B | 72.0% | $676.0M | 8.4% |
| 2019 | $8.60B | +2.6% | $6.25B | 72.7% | $-203,000,000 | -2.4% |
| 2018 | $8.38B | -3.9% | $6.03B | 71.9% | $-2,384,000,000 | -28.4% |
| 2017 | $8.72B | -9.8% | $6.18B | 70.8% | $102.0M | 1.2% |
| 2016 | $9.67B | -7.4% | $7.10B | 73.4% | $-566,000,000 | -5.9% |
See BHC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BHC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BHC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBHC — Frequently Asked Questions
Quick answers to the most common questions about buying BHC stock.
Is BHC's revenue growth accelerating or slowing?
BHC maintains +10.5% revenue growth, in line with its 5-year CAGR of +5.4%. TTM revenue stands at $10.6B. Growth rate remains consistent with historical average.
What is BHC's long-term revenue growth rate?
Bausch Health Companies Inc.'s 5-year revenue CAGR of +5.4% reflects the sustained expansion pattern. Current YoY growth of +10.5% is near this long-term average.
How is BHC's revenue distributed by segment?
BHC reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.